|
1. American Medical Association. Current Procedural Terminology, 2008.
2. Acharya CR, Hsu DS, Anders CK, Anguiano A, et al. Gene expression signatures, clinicopathologic features, and individualized therapy in breast cancer. JAMA 2008; 299:1574-1587.
3. Huang C-C, Bredel M. Use of gene signatures to improve risk estimation in cancer. JAMA 2008; 299:1605-1606.
4. 42 U.S.C. §1395y(a)(1)(A) (2000); see also Centers for Medicare & Medicaid Services, U.S. Dep't of Health and Human Servs., Pub. No. 100-2, Medicare Benefit Policy Manual, ch. 16, § 20, Available at: http://www.cms.hhs.gov/manuals/downloads/bp102c16.pdf.
5. Medicare Program: Revised Process for Making Medicare National Coverage Determinations, 68 Fed. Reg. 55,634 (Sept. 26, 2003), Available at: http://www.cms.hhs.gov/DeterminationProcess/Downloads/FR09262003.pdf.
6. Centers for Medicare & Medicaid Services, U.S. Dep't of Health and Human Servs. Pub. No. 100-8, Medicare Program Integrity Manual, ch. 13, Available at: http://www.cms.hhs.gov/manuals/downloads/pim83c13.pdf.
|